%0 Journal Article
%A Gebhardt, Christoffer
%A Sevko, Alexandra
%A Jiang, Huanhuan
%A Lichtenberger, Ramtin
%A Reith, Maike
%A Tarnanidis, Kathrin
%A Holland-Letz, Tim
%A Umansky, Ludmila
%A Beckhove, Philipp
%A Sucker, Antje
%A Schadendorf, Dirk
%A Utikal, Jochen
%A Umansky, Viktor
%T Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab.
%J Clinical cancer research
%V 21
%N 24
%@ 1557-3265
%C Philadelphia, Pa. [u.a.]
%I AACR
%M DKFZ-2017-02603
%P 5453 - 5459
%D 2015
%X Immunotherapy with ipilimumab improves the survival of patients with metastatic melanoma. Because only around 20
%K Antibodies, Monoclonal (NLM Chemicals)
%K Antineoplastic Agents (NLM Chemicals)
%K Biomarkers (NLM Chemicals)
%K Inflammation Mediators (NLM Chemicals)
%K ipilimumab (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:26289067
%R 10.1158/1078-0432.CCR-15-0676
%U https://inrepo02.dkfz.de/record/126575